Skip to main content
Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.310
-0.020 (-1.50%)
Mar 9, 2026, 2:13 PM EDT - Market open

Pliant Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
171
Market Cap
80.50M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024---
Dec 31, 20231.58M-8.11M-83.69%
Dec 31, 20229.69M2.11M27.91%
Dec 31, 20217.57M-34.25M-81.89%
Dec 31, 202041.82M-15.24M-26.70%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Champions Oncology 58.42M
Verrica Pharmaceuticals 30.83M
Pelthos Therapeutics 7.41M
Pyxis Oncology 2.82M
Coeptis Therapeutics Holdings 501.00K
Seres Therapeutics 351.00K
aTyr Pharma 190.00K
Revenue Rankings

PLRX News

More News